Happy Retirement to Helen Chomicki!
Helen has been working at Vanderbilt since 1989 (29 years), starting in the University for 15 years and then with (what is now) PMI for the last 14. In honor her longevity and dedication to our organization, we wanted to share a little bit about Helen's time here and her plans for the future. She was kind enough to share the following:
Helen, what is your first memory about coming to work at Vanderbilt?
I started working at Vanderbilt when the University and Medical Center were one. I started at the University side. My office was in a building on 2525 West End, what was once called Alexander Hall. Years later, that building was torn down and the new building, what is now there, was built. My first memory was the friendliness of colleagues, the community feeling we all had.
When I came to work at the Medical Center side, I came from an IT background to a people-centered job, I worked recruiting postdocs for the department of Microbiology and Immunology. Through the years, my job evolved to working with faculty, graduate and medical students. Having the support of colleagues made it the best.
What is your fondest memory or favorite thing about working here?
My fond memories revolve around the friends I’ve made thru the years at Vandy. The annual turkey-toss still brings smiles to me and my friends. Don’t get the tofu turkey, there are more delicious ways of getting your tofu.
What do you see yourself doing in your retirement?
In retirement, I plan on spending more time with my family and dear friends, picking back up on the hobbies I’ve set aside, volunteering, spoiling my grandkids.
In addition to traveling to discover new places, I plan to visit family and friends in Poland, England and those in the US.
Do you have a farewell message for your colleagues?
Looking back on the years I spent at Vanderbilt, time really does fly by, make every moment count.
Helen's last day at VUMC will be this Friday, September 14th. Our Second Friday Happy Hour might be your last opportunity to wish her well so don't miss out!
Helen, with her family, at the beach in June (more of this is in her future).
A total of 29 publications came out on Pubmed last month! Congratulations to participating faculty!
September 14, 2018:
Division Happy Hour
Helen's last HH and Mariana Byndloss' first!
4:30pm, 5th Floor Atrium
September 25, 2018:
3pm, room A-5305 MCN
September's Highlighted Lab is The Aiken Lab: Molecular Biology of HIV-1 Infection.
Please consider sharing a lab recruitment poster or publication with visual content to be highlighted on the MP Division page.
Follow and engage with us on Twitter:
Mondays, Noon-1, 214 Light Hall
- 9/10 - VI4 Week
- 9/17 - State of the Department - Sam Santoro, M.D., Ph.D
- 9/24 - Mary Sorci-Thomas, PhD
- 10/1 - TBD (202 Light Hall)
Thursdays, 1-2pm, 1220 MRBIII
- 9/13 - Matt Madden/ Nathaniel Chapman - MPI GS3 - Rathmell/Crowe
- 9/20 - Brenna Appleton/Azi Hadadianpour - MPI GS3 - Rathmell/Crowe
- 9/27 - AVAILABLE
- 10/4 - AVAILABLE
Tuesdays, 10:30am, 512 Light Hall
- 9/11 - Brian Rudd, MPH, Ph.D. (Cornell University)
- 9/25 - Eric Skaar, Ph.D., MPH - State of the Institute Address
- 10/9 - Pamela Bjorkman, Ph.D. (California Institute of Technology)
- 10/23 - Aaron Whiteley, Ph.D. (Harvard Medical School)
Fridays, Noon - 1pm, A4224 MCN
- 9/14 - Lindsay Celada, Ph.D. (Wonder Lab)
- 9/21 - Todd Bartkowiak, PhD. (Irish and Ihrie Labs)
- 9/28 - Diana Contreras (Rathmell, Lab)
- 10/5 - Rachael H. Bonami, Ph.D. (Thomas, Lab)
|Infectious Disease Grand Rounds Schedule
Thursdays, Noon-1pm, A-2200 MCN
| | MP faculty publications: August
- PF74 reinforces the HIV-1 capsid to impair reverse transcription-induced uncoating. Rankovic S, Ramalho R, Aiken C, Rousso I
J Virol. 2018 Aug 08;:
- HIV-1 Engages a Dynein-Dynactin-BICD2 Complex for Infection and Transport to the Nucleus. Carnes SK, Zhou J, Aiken C
J Virol. 2018 Aug 01;:
- Miniaturized Sample Preparation for Transmission Electron Microscopy. Schmidli C, Rima L, Arnold SA, Stohler T, Syntychaki A, Bieri A, Albiez S, Goldie KN, Chami M, Stahlberg H, Braun T
J Vis Exp. 2018 Jul 27;(137):
- Decidual stromal cell-derived PGE2 regulates macrophage responses to microbial threat. Rogers LM, Anders AP, Doster RS, Gill EA, Gnecco JS, Holley JM, Randis TM, Ratner AJ, Gaddy JA, Osteen K, Aronoff DM
Am J Reprod Immunol. 2018 Aug 07;:e13032
- ROCK-nmMyoII, Notch, and Neurog3 gene-dosage link epithelial morphogenesis with cell fate in the pancreatic endocrine-progenitor niche. Bankaitis ED, Bechard ME, Gu G, Magnuson MA, Wright CVE
Development. 2018 Aug 20;:
- Reversible deficits in apical transporter trafficking associated with DGAT1 deficiency. Schlegel C, Lapierre LA, Weis VG, Williams JA, Kaji I, Pinzon-Guzman C, Prasad N, Boone B, Jones A, Correa H, Levy SE, Han X, Wang M, Thomsen K, Acra S, Goldenring JR
Traffic. 2018 Aug 10;:
- Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. Phelps HM, Al-Jadiry MF, Corbitt NM, Pierce JM, Li B, Wei Q, Flores RR, Correa H, Uccini S, Frangoul H, Alsaadawi AR, Al-Badri SAF, Al-Darraji AF, Al-Saeed RM, Al-Hadad SA, Lovvorn Iii HN
World J Pediatr. 2018 Aug 28;:
- Physical activity is related to function and fatigue but not pain in women with fibromyalgia: baseline analyses from the Fibromyalgia Activity Study with TENS (FAST). Merriwether EN, Frey-Law LA, Rakel BA, Zimmerman MB, Dailey DL, Vance CGT, Golchha M, Geasland KM, Chimenti RCrofford LJ, Sluka KA
Arthritis Res Ther. 2018 Aug 29;20(1):199
- A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, Lai J, Chandran K, Zeitlin L, Crowe JE, Lauffenburger D, Kawaoka Y, Kobinger GP, Andersen KG, Dye JM, Saphire EO, Alter G
Cell Host Microbe. 2018 Aug 08;24(2):221-233.e5
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, Krause TB, Turner HL, Murin CD, Pallesen J, Davidson E, Ahmed R, Aman MJ, Bukreyev A, Burton DR, Crowe JE, Davis CW, Georgiou G, et al.
Cell. 2018 Aug 09;174(4):938-952.e13
- Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, Pettitt J, Logue J, Marchand J, Varughese J, Bennett RS, Jahrling P, Cavet G, Serafini T, Ollmann Saphire E, Vilain E, Muyembe-Tamfum JJ, Hensely LE, Simmons G, Crowe JE, Rimoin AW
J Infect Dis. 2018 Aug 13;:
- Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors. Meyer M, Yoshida A, Ramanathan P, Saphire EO, Collins PL, Crowe JE, Samal S, Bukreyev A
Cell Rep. 2018 Aug 14;24(7):1816-1829
- Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Kuzmina NA, Younan P, Gilchuk P, Santos RI, Flyak AI, Ilinykh PA, Huang K, Lubaki NM, Ramanathan P, Crowe JE, Bukreyev A
Cell Rep. 2018 Aug 14;24(7):1802-1815.e5
- Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. Ilinykh PA, Santos RI, Gunn BM, Kuzmina NA, Shen X, Huang K, Gilchuk P, Flyak AI, Younan P, Alter G, Crowe JE, Bukreyev A
PLoS Pathog. 2018 Aug;14(8):e1007204
- Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Alvarado G, Ettayebi K, Atmar RL, Bombardi RG, Kose N, Estes MK, Crowe JE
Gastroenterology. 2018 Aug 28;:
- An integrated, high-throughput strategy for multi-omic systems level analysis. Gutierrez DB, Gant-Branum RL, Romer CE, Farrow MA, Allen JL, Dahal N, Nei YW, Codreanu SG, Jordan AT, Palmer LD, Sherrod SD, McLean JA, Skaar EP, Norris JL, Caprioli RM
J Proteome Res. 2018 Aug 16;:
- Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy. Kallianpur AR, Gerschenson M, Hulgan T, Kaur H, Clifford DB, Haas DW, Murdock DG, McArthur JC, Samuels DC, Simpson DM
AIDS Res Hum Retroviruses. 2018 Aug 22;:
- Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies. Greenplate A, Wang K, Tripathi RM, Palma N, Ali SM, Stephens PJ, Miller VA, Shyr Y, Guo Y, Reddy NM, Kozhaya L, Unutmaz D, Chen X, Irish JM, Davé UP
JCO Precis Oncol. 2018;2018:
- Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines. Qiu F, Becker KW, Knight FC, Baljon JJ, Sevimli S, Shae D, Gilchuk P, Joyce S, Wilson JT
Biomaterials. 2018 Jul 30;182:82-91
- Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Karnes JH, Miller MA, White KD, Konvinse KC, Pavlos RK, Redwood AJ, Peter JG, Lehloenya R,Mallal SA, Phillips EJ
Annu Rev Pharmacol Toxicol. 2018 Aug 22;:
- Healthy Donor Polyclonal IgM's Diminish B Lymphocyte Autoreactivity, Enhance Treg Generation, and Reverse T1D in NOD Mice. Wilson CS, Chhabra P, Marshall AF, Morr CV, Stocks BT, Bonami RH, Poffenberger G, Brayman KL, Moore DJ
Diabetes. 2018 Aug 21;:
- Testosterone Decreases House Dust Mite-Induced Type 2 and IL-17A-Mediated Airway Inflammation. Fuseini H, Yung JA, Cephus JY, Zhang J, Goleniewska K, Polosukhin VV, Peebles RS, Newcomb DC
J Immunol. 2018 Aug 20;:
- The PGI2 Analog Cicaprost Inhibits IL-33-Induced Th2 Responses, IL-2 Production, and CD25 Expression in Mouse CD4+ T Cells. Zhou W, Zhang J, Toki S, Goleniewska K, Johnson MO, Bloodworth MH, Newcomb DC, Peebles RS
J Immunol. 2018 Aug 20;:
- Lymphocyte Deficiency Induced by Sublethal Irradiation in Xenopus. Rollins-Smith LA, Robert J
Cold Spring Harb Protoc. 2018 Aug 13;:
- Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice. Brandt SL, Klopfenstein N, Wang S, Winfree S, McCarthy BP, Territo PR, Miller L, Serezani CH
PLoS Pathog. 2018 Aug 13;14(8):e1007244
- Intestinal host defense outcome is dictated by PGE2 production during efferocytosis of infected cells. Dejani NN, Orlando AB, Niño VE, Penteado LA, Verdan FF, Bazzano JMR, Codo AC, Salina ACG, Saraiva AC, Avelar MR, Spolidorio LC, Serezani CH, Medeiros AI
Proc Natl Acad Sci U S A. 2018 Aug 20;:
- Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma. Reilly JP, Zhao Z, Shashaty MGS, Koyama T, Christie JD, Lanken PN, Wang C, Balmes JR, Matthay MA, Calfee CS, Ware LB
Am J Respir Crit Care Med. 2018 Aug 01;:
- Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. Vagner T, Spinelli C, Minciacchi VR, Balaj L, Zandian M, Conley A, Zijlstra A, Freeman MR, Demichelis F, De S, Posadas EM, Tanaka H, Di Vizio D
J Extracell Vesicles. 2018;7(1):1505403
- Emerin deregulation links nuclear shape instability to metastatic potential. Reis-Sobreiro M, Chen JF, Novitskaya T, You S, Morley S, Steadman K, Kaur Gill N, Eskaros A, Rotinen M, Chu CY, Chung LWK, Tanaka H, Yang W, Knudsen BS, Tseng HR, Rowat AC, Posadas EM, Zijlstra A, Di Vizio D, Freeman MR
Cancer Res. 2018 Aug 28;: